The forecasted data for liver malignant neoplasms mortality in Japan shows a decreasing trend from 2024 through 2028. In 2023, the mortality value should be consulted to establish a baseline for these projections. Year-on-year variations indicate a consistent decline: -2.58% from 2024 to 2025, -2.57% from 2025 to 2026, -2.57% from 2026 to 2027, and -2.64% from 2027 to 2028. This results in a compound annual growth rate (CAGR) of approximately -2.59% over these five years.
Future trends to watch for include advancements in early detection and treatment, shifts in healthcare policy focusing on cancer prevention, and potential societal changes impacting risk factor prevalence such as diet or alcohol consumption.
